| __timestamp | Iovance Biotherapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 94103000 |
| Thursday, January 1, 2015 | 999000 | 146194000 |
| Friday, January 1, 2016 | 978000 | 130000 |
| Sunday, January 1, 2017 | 952000 | 7353000 |
| Monday, January 1, 2018 | 956000 | 34193000 |
| Tuesday, January 1, 2019 | 8122999 | 56586000 |
| Wednesday, January 1, 2020 | 8712000 | 63382000 |
| Friday, January 1, 2021 | 13980000 | 97049000 |
| Saturday, January 1, 2022 | 21135000 | 139989000 |
| Sunday, January 1, 2023 | 10755000 | 150343000 |
Data in motion
In the dynamic world of biotechnology, cost management is crucial for success. This chart compares the cost of revenue for Sarepta Therapeutics, Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, Sarepta consistently outpaced Iovance, with costs peaking at approximately $150 million in 2023, a staggering 1,500% increase from 2016. In contrast, Iovance's costs remained relatively stable, with a notable spike in 2022, reaching around $21 million, a 120% rise from 2021. This disparity highlights Sarepta's aggressive growth strategy, while Iovance maintains a more conservative approach. The data underscores the importance of strategic financial planning in the biotech sector, where innovation and cost efficiency must go hand in hand. As these companies continue to evolve, their financial strategies will be pivotal in shaping their future trajectories.
Cost of Revenue Trends: Johnson & Johnson vs Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Sarepta Therapeutics, Inc.
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses
MorphoSys AG vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored